BIVI
BIOVIE INC.
Next earnings Aug 13, 2026 (after close) · consensus $-0.53 EPS
$1.94
▲ +8.99%$1.94▼ -80.79%
over 1Y
L $1.06EODHDH $10.70
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.0%
1W+0.0%
1M+31.1%
3M+42.6%
YTD+45.9%
1Y-80.8%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.13x).
Return on equity -92.3% · latest
BIOVIE INC. shows limited reported revenue, and -92.3% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$138M | -$27.3M | -$45.1M | -$32.2M | -$18.1M |
| Net income | -$130M | -$26.1M | -$50.3M | -$32.1M | -$17.5M |
| Diluted EPS | -$14.82 | -$1.06 | -$15.47 | -$73.05 | -$12.12 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value-$2.87M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-120.0%
FCF yield—
Quality & risk
ROIC (est.)-74.8%
Free cash flow—
Total debt$62.5K
Net cash$17.5M
Piotroski F-Score3/6
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-5.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- S-3 Shelf registration (potential raise)2026-06-18
- 10-Q Quarterly report2026-05-11
- 10-Q Quarterly report2026-02-06
- 8-K Officer / director change2025-11-13
- 8-K Shareholder vote2025-11-12
- 10-Q Quarterly report2025-11-10
- DEF 14A Proxy statement2025-09-25
- 10-K Annual report2025-08-15
- 8-K Material agreement2025-08-11
Recent filings
all on EDGAR ↗S-3Filing2026-06-18open ↗10-QPeriod ending 2026-03-312026-05-11open ↗SCHEDULE 13DFiling2026-03-25open ↗10-QPeriod ending 2025-12-312026-02-06open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗4Period ending 2026-01-052026-01-09open ↗
Frequently asked
- Is BIOVIE INC. (BIVI) a buy?
- BIVI currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.13x).
- What is BIOVIE INC.'s quality score?
- BIVI scores 59.87179487179487/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001580149, latest 10-Q filed 2026-05-11) · EODHD · as of 6/26/2026, 7:10:48 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.